Targeted drug delivery to mammalian mitochondria in living cells

Bibliography

• LARSSON N-G, LUFT R: Revolution in mitochondrial medicine. FEBS Lett. (1999) 455:199–202.
   PubMed Web of Science ®Google Scholar
• •Important review written by one of the early pioneers in this field. For the very first time, a paper authored by Luft and published in Nature describes in 1959 symptoms of a mitochondrial disease later termed Tuft Diseases' (Nature (1959) 184:1851–1854).
   Google Scholar
• SCHON EA, DIMAURO S: Medicinal and genetic approaches to the treatment of mitochondrial disease. Curr. Med. Chem. (2003) 10:1241–1253.
   Web of Science ®Google Scholar
• •An up-to-date review of currently used rational therapies of mitochondrial disorders due to defects in the respiratory chain.
   Google Scholar
• MURPHY MP, SMITH RA: Drug delivery to mitochondria: the key to mitochondrial medicine. Adv. Drug Deliv. Rev. (2000) 41:235–250.
   PubMed Web of Science ®Google Scholar
• •Comprehensive review written by the pioneers of mitochondria-specific drug delivery based on stoichiometric carrier systems; that is, triphenylphosphonium conjugates.
   Google Scholar
• MANELLA CA: Our changing views of mitochondria. J. Bioenerg. Biomembr. (2000) 32:1–4.
   PubMed Web of Science ®Google Scholar
• PERKINS GA, FREY TG: Recent structural insight into mitochondria gained by microscopy. Micron (2000) 31:97–111.
   PubMed Web of Science ®Google Scholar
• SCHEFFLER IE: Mitochondria make a come back. Adv. Drug Deliv. Rev. (2001) 49:3–26.
   PubMed Web of Science ®Google Scholar
• •As further reading, Scheffler's book 'Mitochondria', covering literally all aspects of this organelle, is highly recommended.
   Google Scholar
• WEISSIG V BODDAPATI SV, D'SOUZA GGM, CHENG SM: Targeting of Low-Molecular Weight Drugs to Mammalian Mitochondria. Drug Design Reviews - Online (2004) 1:15–28.
   Google Scholar
• MORISAKI T, KATANO M: Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer. Curr. Med. Chem. (2003) 10:2517–2521.
   PubMed Web of Science ®Google Scholar
• KOTAKE Y, OHTA S: MPP+ analogs acting on mitochondria and inducing neuro-degeneration. Curr. Med. Chem. (2003) 10:2507–2516.
   PubMed Web of Science ®Google Scholar
• KROEMER G: The mitochondrial permeability transition pore complex as a pharmacological target. An introduction. Curr. Med. Chem. (2003) 10:1469–1472.
   PubMed Web of Science ®Google Scholar
• ••Kroemer is one of the leading authoritiesin the area of mitochondria-mediated programmed cell death. For further reading, a most recently published review about the pathophysiology of mitochondrial cell death authored by Kroemer and Green in Science (2004) 305:626-629 is recommended.
   Google Scholar
• MALISAN F, TESTI R: Mitochondrial lipids as apoptosis regulators. Curr. Med. Chem. (2003) 10:1573–1580.
   PubMed Web of Science ®Google Scholar
• GALIEGUE S, TINEL N, CASELLAS P: The peripheral benzodiazepine receptor: a promising therapeutic drug target. Curr. Med. Chem. (2003) 10:1563–1572.
   PubMed Web of Science ®Google Scholar
• O'NEILL JW, HOCKENBERY DM: Bcl-2-related proteins as drug targets. Curr. Med. Chem. (2003) 10:1553–1562.
   PubMed Web of Science ®Google Scholar
• PASTORINO JG, HOEK JB: Hexokinase II: the integration of energy metabolism and control of apoptosis. Curr. Med. Chem. (2003) 10:1535–1551.
   PubMed Web of Science ®Google Scholar
• GRANVILLE DJ, GOTTLIEB RA: The mitochondrial voltage-dependent anion channel (VDAC) as a therapeutic target for initiating cell death. Curr. Med. Chem. (2003) 10:1527–1533.
   PubMed Web of Science ®Google Scholar
• HALESTRAP AP, BRENNERB C: The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Cuff. Med. Chem. 2003;10:1507–1525.
   PubMed Web of Science ®Google Scholar
• WALDMEIER PC, ZIMMERMANN K, QIAN T, TINTELNOT-BLOMLEY M, LEMASTERS JJ: Cyclophilin D as a drug target. Curr. Med. Chem. (2003)10:1485–1506.
   PubMed Web of Science ®Google Scholar
• CROMPTON M: On the involvement of mitochondrial intermembrane junctional complexes in apoptosis. Curr. Med. Chem. (2003) 10:1473–1484.
   PubMed Web of Science ®Google Scholar
• SORDET O, KHAN QA, KOHN KW, POMMIER Y: Apoptosis induced by topoisomerase inhibitors. Curr. Med. Chem. Anti-Canc. Agents (2003) 3:271–290.
   PubMedGoogle Scholar
• KROEMER G: Mitochondrial control ofapoptosis: an overview. In: Mitochondria and Cell Death. Brown GC, Nicholls DG, Cooper CE (Eds.). Princton University Press: Princton, NJ (1999):1–15.
   Google Scholar
• JAMES AM, SMITH RA, MURPHY MP: Antioxidant and prooxidant properties of mitochondrial Coenzyme Q. Arch. Biochem. Biophys. (2004) 423:47–56.
   PubMed Web of Science ®Google Scholar
• GREEN K, BRAND MD, MURPHY MP: Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes (2004) 53\(Suppl. 1):5110–S118.
   Google Scholar
• COULTER CV KELSO GF, LIN TK, SMITH RA, MURPHY MP: Mitochondrially targeted antioxidants and thiol reagents. Free Radic. Biol. Med. (2000) 28:1547–1554.
   PubMed Web of Science ®Google Scholar
• FRIDOVICH I: Mitochondria: are they theseat of senescence? Aging Cell (2004) 3:13–16.
   PubMed Web of Science ®Google Scholar
• SZEWCZYK A, WOJTCZAK L: Mitochondria as a pharmacological target. Pharmacol Rev. (2002) 54:101–127.
   PubMed Web of Science ®Google Scholar
• •Excellent and very comprehensive review of mitochondrially localised potential targets for therapeutic interventions.
   Google Scholar
• SMITH RA, PORTEOUS CM, COULTER CV MURPHY MP: Selective targeting of an antioxidant to mitochondria. Eur. J. Biochem. (1999) 263:709–716.
   PubMedGoogle Scholar
• DIMAURO S, SCHON EA: Mitochondrial DNA mutations in human disease. Am. J. Med. Genet. (2001) 106:18–26.
   PubMed Web of Science ®Google Scholar
• WALLACE DC: Diseases of the mitochondrial DNA. Ann. Rev. Biochem. (1992) 61:1175–1212.
   PubMed Web of Science ®Google Scholar
• ••An early review about (then) a new field of biomedical research written by an author who revealed for the very first time the causative link between mitochondrial DNA mutations and human diseases. Compare the landmark paper: Wallace DC, et al.: Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy Science (1988) 242(4884):1427–1430.
   Google Scholar
• WALLACE DC: A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found Symp. (2001) 235:247–263.
   PubMedGoogle Scholar
• PULKES T, HANNA MG: Human mitochondrial DNA diseases. Adv. Drug Dekv. Rev. (2001) 49:27–43.
   PubMed Web of Science ®Google Scholar
• MANFREDI G, BEAL MF: The role of mitochondria in the pathogenesis of neurodegenerative diseases. Brain Pathol (2000) 10:462–472.
   PubMed Web of Science ®Google Scholar
• D'SOUZA GGM, WEISSIG V: Approaches to mitochondrial gene therapy. Curr. Gene Ther. (2004) 4:317–328.
   PubMed Web of Science ®Google Scholar
• •Most recent and most comprehensive review of all currently pursued approaches to direct mitochondrial gene therapy.
   Google Scholar
• GANITKEVICH VY: The role of mitochondria in cytoplasmic Ca2* cycling. Exp. Physiol (2003) 88:91–97.
   PubMed Web of Science ®Google Scholar
• WATTS JA, KLINE JA: Bench to bedside: the role of mitochondrial medicine in the pathogenesis and treatment of cellular injury. Acad. Emerg. Med. (2003) 10:985–997.
   PubMed Web of Science ®Google Scholar
• RIZZUTO R, BERNARDI P, POZZAN T: Mitochondria as all-round players of the calcium game. J. Physiol (2000) 529 (Pt 0:37–47.
   PubMedGoogle Scholar
• BERNARDI P: Mitochondrial transport ofcations: channels, exchangers, and permeability transition. Physiol Rev. (1999) 79:1127–1155.
   PubMed Web of Science ®Google Scholar
• KIRICHOK Y, KRAPIVINSKY G, CLAPHAM DE: The mitochondrial calcium uniporter is a highly selective ion channel. Nature (2004) 427:360–364.
   PubMed Web of Science ®Google Scholar
• RUPP H, ZARAIN-HERZBERG A, MAISCH B: The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz (2002) 27:621–636.
   PubMed Web of Science ®Google Scholar
• DUVVURI M, FENG W, MATHIS A, KRISE JP: A cell fractionation approach for the quantitative analysis of subcellular drug disposition. Pharm. Res. (2004) 21:26–32.
   PubMed Web of Science ®Google Scholar
• •By developing an easy-to-use method for the analysis of drug distribution inside a mammalian cell, these authors make an important contribution towards the development of `subcellular pharmaceutics'.
   Google Scholar
• LUKACS GL, HAGGIE P, SEKSEK O, LECHARDEUR D, FREEDMAN N, VERKMAN AS: Size-dependent DNA mobility in cytoplasm and nucleus. J. Biol. Chem. (2000) 275:1625–1629.
   PubMed Web of Science ®Google Scholar
• ••These authors have measured directly andfor the very first time the diffusion rate of DNA inside the cytoplasm and the nucleus.
   Google Scholar
• SEKSEK O, BIWERSI J, VERKMAN AS: Translational diffusion of macromolecule-sized solutes in cytoplasm and nucleus. J. Cell Biol. (1997) 138:131–142.
   PubMed Web of Science ®Google Scholar
• FUSHIMI K, VERKMAN AS: Low viscosity in the aqueous domain of cell cytoplasm measured by picosecond polarization microfluorimetry. J. Cell Biol. (1991) 112:719–725.
   PubMed Web of Science ®Google Scholar
• SODEIK B, EBERSOLD MW, HELENIUS A: Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol. (1997) 136:1007–1021.
   PubMed Web of Science ®Google Scholar
• KAO HP, ABNEY JR, VERKMAN AS: Determinants of the translational mobility of a small solute in cell cytoplasm. J. Cell Biol. (1993) 120:175–184.
   PubMed Web of Science ®Google Scholar
• LEDLEY FD: Pharmaceutical approach to somatic gene therapy. Pharm. Res. (1996) 13:1595–1614.
   PubMed Web of Science ®Google Scholar
• HOROBIN RW: Biological staining: mechanisms and theory. Biotech. Histochem. (2002) 77:3–13.
   PubMed Web of Science ®Google Scholar
• HOROBIN RW: Uptake, distribution and accumulation of dyes and fluorescent probes within living cells: a structure-activity modelling approach. Adv. Colour Sci. TechnoL (2001) 4:101–107.
   Google Scholar
• ••This author has developed a QSARmodelling approach for predicting the intracellular distribution of fluorescent probes, which should also be applicable to xenobiotics and pharmaceuticals.
   Google Scholar
• WOODFIELD K, RUCK A, BRDICZKA D, HALESTRAP AP: Direct demonstration of a specific interaction between cyclophilin D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem. J. (1998) 336:287–290.
   PubMed Web of Science ®Google Scholar
• WEISSIG V, CHENG SM, D'SOUZA G: Mitochondrial pharmaceutics. Mitochondrion (2004) 3:229–244.
   PubMed Web of Science ®Google Scholar
• SRERE PA: The infrastructure of the mitochondrial matrix. Trends Biochem. Sci. (1980) 5:120–121.
   Web of Science ®Google Scholar
• GOODSELL DS: Inside a living cell. Trends Biochem. Sci. (1991) 16:203–206.
   PubMed Web of Science ®Google Scholar
• WEISSIG V: Mitochondrial-targeted drug and DNA delivery. Crit. Rev. Ther. Drug Carrier Syst. (2003) 20:1–62.
   PubMed Web of Science ®Google Scholar
• PARTIKIAN A. OLVECZKY B, SWAMINATHAN R, LI Y, VERKMAN AS: Rapid diffusion of green fluorescent protein in the mitochondrial matrix. J. Cell Biol. (1998) 140: 821–829.
   Google Scholar
• MURPHY MP: Selective targeting of bioactive compounds to mitochondria. Trends Biotechnol (1997) 15:326–330.
   PubMed Web of Science ®Google Scholar
• MURATKOVSKA A, LIGHTOWLERS RN, TAYLOR RW, WILCE JA, MURPHY MP: Targeting large molecules to mitochondria. Adv. DrugDeliv. Rev. (2001) 49:189–198.
   PubMed Web of Science ®Google Scholar
• PAUNESKU T, VOGT S, MASER J et al.: Development of nanocomposites with mitochondrial specifity (Abstract). Mitochondrion (2004) 4:75–76.
   Web of Science ®Google Scholar
• MURPHY MP: Slip and leak in mitochondrial oxidative phosphorylation. Biochim. Biophys. Acta (1989) 977:123–141.
   PubMed Web of Science ®Google Scholar
• KOEHLER CM: Protein translocation pathways of the mitochondrion. FEBS Lett. (2000) 476:27–31.
   PubMed Web of Science ®Google Scholar
• LITHGOW T: Targeting of proteins to mitochondria. FEBS Lett. (2000) 476:22–26.
   PubMed Web of Science ®Google Scholar
• CHINNERY PF, TAYLOR RW, DIEKERT K, LILL R, TURNBULL DM, LIGHTOWLERS RN: Peptide nucleic acid delivery to human mitochondria. Gene Ther. (1999) 6:1919–1928.
   PubMed Web of Science ®Google Scholar
• •First description of the successful delivery of PNAs into the mitochondrial matrix within living mammalian cells via the mitochondrial protein import pathway.
   Google Scholar
• FLIERL A, JACKSON C, COTTRELL B, MURDOCK D, SEIBEL P, WALLACE DC: Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid. MoL Ther. (2003) 7:550–557.
   PubMed Web of Science ®Google Scholar
• ••These authors provide detailed evidencefor the matrix localisation of oligonucleotide MLS peptide conjugates within mammalian cells following polyplex-mediated cell internalisation. Expert Op/n. Drug Deliv. (2005) 2(1)
   PubMedGoogle Scholar
• GEROMEL V, GAO A, BRIANE D: Mitochondria transfection by oligonucleotides containing a signal peptide and vectorized by cationic liposomes. Antisense Nucleic Acid Drug Dev. (2001) 11:175–180.
   PubMedGoogle Scholar
• MIHARA K, OMURA T: Cytoplasmic chaperones in precursor targeting to mitochondria: the role of MSF and hsp 70. Trends Cell Biol. (1996) 6:104–108.
   PubMed Web of Science ®Google Scholar
• MIHARA K, OMURA T: Cytosolic factors in mitochondrial protein import. Experientia (1996) 52: 1063–1068.
   Google Scholar
• DEL GAIZO V, PAYNE RM: A novel TAT-Mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta. MoL Ther. (2003) 7:720–730.
   PubMed Web of Science ®Google Scholar
• ••First paper describing the use of cell-penetrating peptides for the mitochondrial import of bioactive molecules.
   Google Scholar
• DEL GAZIO V, MACKENZIE JA, PAYNE RM: Targeting proteins to mitochondria using TAT. MoL Genet. Metab. (2003) 80:170–180.
   PubMed Web of Science ®Google Scholar
• ROSS MF, FILIPOVSKA A, SMITH RA, GAIT MJ, MURPHY MP: Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers. Biochem. j (2004).
   PubMedGoogle Scholar
• ••In contrast to references [65,66], this paperprovides data supporting the inability of cell-penetrating peptides to cross the mitochondrial inner membrane.
   Google Scholar
• CHEN LB, SUMMERHAYES IC, JOHNSON LV, WALSH, ML, BERNAL, SD, LAMPIDIS TJ: Probing mitochondria in living cells with rhodamine 123. Cold Spring Harb. Symp. Quant. Biol. (1982) 46:141–155.
   PubMedGoogle Scholar
• ••Landmark paper opening up avenues forthe development of mitochondria-specific dyes.
   Google Scholar
• LIBERMAN EA, TOPALY VP, TSOFINA LM, JASAITIS AA, SKULACHEV VP: Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria. Nature (1969) 222:1076–1078.
   PubMed Web of Science ®Google Scholar
• WEISS MJ, WONG JR, HA CS: Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation. Proc. Natl. Acad. Sci. USA (1987) 84:5444–5448.
   PubMed Web of Science ®Google Scholar
• •This paper demonstrates for the first time the ability of dequalinium to accumulate selectively in mitochondria in response to the mitochondrial membrane potential within living mammalian cells.
   Google Scholar
• OSEROFF AR, OHUOA D, ARA G, MCAULIFFE D, FOLEY J, CINCOTTA L: Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells. Proc. Nail. Acad. Sci. USA (1986) 83:9729–9733.
   PubMed Web of Science ®Google Scholar
• MORGAN J, WHITAKER JE, OSEROFF AR: GRP78 induction by calcium ionophore potentiates photodynamic therapy using the mitochondrial targeting dye victoria blue BO. Photochem. PhotobioL (1998) 67:155–164.
   PubMed Web of Science ®Google Scholar
• MURPHY MP: Development of lipophilic cations as therapies for disorders due to mitochondrial dysfunction. Expert Opin. Biol. Ther. (2001) 1:753–764.
   PubMed Web of Science ®Google Scholar
• ••Excellent review written by one of thepioneers in this field.
   Google Scholar
• JAMES AM, BLAIKIE FH, SMITH RA, LIGHTOWLERS RN, SMITH PM, MURPHY MP: Specific targeting of a DNA-alkylating reagent to mitochondria. Synthesis and characterization of [4-((11aS)-7-methoxy-1,2,3,11a-tetrahydro- 5H-pyrrolo11,4lbenzodiaze pin-5-on-8-oxy)butyll -triphenylphosphonium iodide. Eur. j Biochem. (2003) 270:2827–2836.
   PubMedGoogle Scholar
• KELSO GF, PORTEOUS CM, COULTER CV, SMITH RA, MURPHY MP: Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J. Biol. Chem. (2001) 276:4588–4596.
   PubMed Web of Science ®Google Scholar
• BURNS RJ, SMITH RA, MURPHY MP: Synthesis and characterization of thiobutyltriphenylphosphonium bromide, a novel thiol reagent targeted to the mitochondrial matrix. Arch. Biochem. Biophys. (1995) 322:60–68.
   PubMed Web of Science ®Google Scholar
• MURATOVSKAA, LIGHTOWLERS RN, TAYLOR RW, SMITH RA, MURPHY MP: Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease. Nucleic Acids Res. (2001) 29:1852–1863.
   PubMed Web of Science ®Google Scholar
• SMITH RA, PORTEOUS CM, GANE AM, MURPHY MP: Delivery of bioactive molecules to mitochondria in vivo. Proc. Nail. Acad. Sci. USA (2003) 100: 5407–5412.
   PubMed Web of Science ®Google Scholar
• D'SOUZA GG, RAMMOHAN R, CHENG SM, TORCHILIN VP, WEISSIG V: DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells. J. Control. Release (2003) 92:189–197.
   PubMed Web of Science ®Google Scholar
• WEISSIG V, LIZANO C, TORCHILIN VP: Selective DNA release from DQAsome/ DNA complexes at mitochondria-like membranes. Drug Deliv. (2000) 7:1–5.
   PubMed Web of Science ®Google Scholar
• WEISSIG V, D' DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria. J. Control. Release (2001) 75:401–408.
   PubMed Web of Science ®Google Scholar
• WEISSIG V, LIZANO C, GANELLIN CR, TORCHILIN VP: DNA binding cationic bolasomes with delocalized charge center: a structure-activity relationship study. S. TB Pharma Sciences (2001) 11:91–96.
   Web of Science ®Google Scholar
• WEISSIG V, LASCH J, ERDOS G, MEYER HW, ROWE TC, HUGHES J: DQAsomes: a novel potential drug and gene delivery system made from Dequalinium. Pharm. Res. (1998) 15:334–337.
   PubMed Web of Science ®Google Scholar
• WEISSIG V, MOGEL HJ, WAHAB M, LASCJ J: Computer simulations of DQAsomes Intl. Symp. Control. Rel. Bioact. Mater. Controlled Release Society, Las Vegas, Nevada, USA (1998):312.
   Google Scholar
• LASCH J, MEYE A. TAUBERT H, KOELSCH R, MANSA-ARD J, WEISSIG V: Dequalinium vesicles form stable complexes with plasmid DNA which are protected from DNase attack. Biol. Chem. (1999) 380:647–652.
   PubMed Web of Science ®Google Scholar
• WEISSIG V, TORCHILIN VP: Towards mitochondrial gene therapy: DQAsomes as a strategy. J. Drug Target. (2001) 9:1–13.
   PubMed Web of Science ®Google Scholar
• WEISSIG V, TORCHILIN VP: Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems. Adv. Drug Deliv. Rev. (2001) 49:127–149.
   PubMed Web of Science ®Google Scholar
• WEISSIG V, CHENG SM, D'SOUZA GG, TORCHILIN VP, SCHUBERT R, KIMPFLER A: Towards mitochondria-specific delivery of apoptosis-inducing agents: DQAsomal incorporated paclitaxel Intl. Symp. Control. Rel. Bioact. Mater. Controlled Release Society. Glasgow, Scotland (2003).
   Google Scholar
• EISENHAUER EA, VERMORKEN JB: The taxoids. Comparative clinical pharmacology and therapeutic potential. Drugs (1998) 55:5–30.
   PubMed Web of Science ®Google Scholar
• ANDRE N, CARRE M, BRASSEUR G: Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells. FEBS Lett. (2002) 532:256–260.
   PubMed Web of Science ®Google Scholar
• SELIGSON AL, TERRY RC, BRESSI JC, DOUGLASS JG 3rd, SOVAK M: A new prodrug of paclitaxel: synthesis of Protaxel. Anti-Cancer Drugs (2001) 12:305–313.
   PubMed Web of Science ®Google Scholar
• CHEN LB: Mitochondrial membrane potential in living cells. Ann. Rev. Cell Biol. (1988) 4:155–181.
   PubMedGoogle Scholar
• MODICA-NAPOLITANO JS, APRILLE JR: Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv. Drug Deliv. Rev. (2001) 49:63–70.
   PubMed Web of Science ®Google Scholar
• MODICA-NAPOLITANO JS, APRILLE JR: Basis for the selective cytotoxicity of rhodamine 123. Cancer Res. (1987) 47:4361–4365.
   PubMed Web of Science ®Google Scholar
• KLIBANOV AL, MARUYAMA K, TORCHILIN VP, HUANG L: Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. (1990) 268: 235–237.
   Google Scholar
• LASCH J, WEISSIG V, BRANDL M: Preparation of liposomes. In: Liposomes —A Practical Approach. Torchilin VP, Weissig V (Eds). Oxford University Press, Oxford (2003):3–30.
   Google Scholar
• TORCHILIN VP, WEISSIG V, MARTIN FJ, HEATH TD, NEW RRC: Surface modification of liposomes. In: Liposomes — A Practical Approach. Torchilin VP, Weissig, V, (Eds). Oxford University press, Oxford (2003):193–230.
   Google Scholar
• SCHWARZE SR, HO A, VOCERO-AKBANI A, DOWDY SF: In vivo protein transduction: delivery of a biologically active protein into the mouse. Science (1999) 285:1569–1572.
   PubMed Web of Science ®Google Scholar
• TREHIN R, MERKLE HP: Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur. j Pharm. Biopharm. (2004) 58:209–223.
   PubMed Web of Science ®Google Scholar
• SNYDER EL, DOWDY SF: Cell penetrating peptides in drug delivery. Pharm. Res. (2004) 21:389–393.
   PubMed Web of Science ®Google Scholar
• JARVER P, LANGEL U: The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov. Today (2004) 9:395–402.
   PubMed Web of Science ®Google Scholar
• TORCHILIN VP, LEVCHENKO TS: TAT-liposomes: a novel intracellular drug carrier. Curr. Protein Pept. Sci. (2003) 4:133–140.
   PubMed Web of Science ®Google Scholar